Chief Executive Officer in waiting – Biotech – Ref.: JVM140818K
Our client is a biotechnology company, established in 2006 to satisfy the overwhelming need for more human relevant science brought about by the failures of traditional in vitro research and animal research models; the Company’s proprietary technology being popularly known as “organ-on-a-chip”.
The current CEO is looking to step back and the company needs to transition in a new CEO to take the company forward to raise the next round of funding. They require a candidate that’s willing to come on board to refine the business plan and meet with investors, on a part time basis at first, for sweat equity initially, and transitioning into a full time paid post once funding is secured. The role holder will have relevant personal experience in the development and commercialisation of novel technology in the preclinical and / or toxicology arena. Previous positions at CEO or senior level executive with the personal credibility to make an early impact, ideally with evidence of closing previous deals and successful business exits. Established successful relationships with early stage investors and institutions is essential.